Experts

Home
Experts

Will be updated soon

Alan M. Lambowitz

Alan M. Lambowitz

Professor

The University of Texas at Austin, TX

Rudolf Jaenisch

Rudolf Jaenisch

Professor

MIT, MA

Ula V. Jurkunas

Ula V. Jurkunas

Associate Professor of Ophthalmology

Harvard Medical School, MA

Jerome Chal

SVP, Head of CMC

Myeloid Therapeutics, MA

Luis Pereira de Almeida

Luis Pereira de Almeida

President

CNC UC, Portugal

Lynne Frick

President & CEO

Cell X Technologies, OH

Rachel Salzman

CEO

Armatus Bio, OH

Joseph Pekny

Co-Founder/CEO

Advanced Process Combinatorics Inc., IN

Irene Rombel

CEO and Co-founder

BioCurie, DE

David McNally

Head of Viral Vector Technology

MassBiologics, MA

Chang Li

Assistant Professor

University of Washington, WA

Moritz von Stosch

Moritz von Stosch

Chief Innovation Officer

Datahow, Switzerland

Jason Criscione

Jason Criscione

Chief Scientific Officer

Enquyst Technologies, Inc., MA

Kira Gillett

Program Manager, Translational Science

FNIH, MD

Hiroshi Sugimoto

Hiroshi Sugimoto

Associate Director

Takeda Development Center Americas Inc., MA

Kimberley Buytaert-Hoefen

Kimberley Buytaert-Hoefen

Executive Director & Global Head of Regulatory Affairs

QPS LLC, DE

Amir Hefni

Chief Executive Officer

Resolution Therapeutics, UK

Xingxing Zang

Louis Goldstein Swan Chair in Cancer Research

Albert Einstein College of Medicine, NY

Yuechao Zhao

Director, R&D

Celularity Inc., NJ

Nick Lai

Senior Scientist

Regeneron Pharmaceuticals, NY

Larry Forman

Founder and CEO

CHO Plus, Inc., CA

Asaf Hellman

Professor

The Hebrew University, Israel

Dr. Anand Srivastava

Anand Srivastava

Chairman and Cofounder

Global Institute of Stem Cell Therapy and Research (GIOSTAR), CA

Susan M. Faust

Patent Specialist

Hogan Lovells US LLP, DC

Ruby Tsai

CEO & Co-Founder

Applied StemCell, CA

Liping Yu

VP, Application

Applied Cells, CA

John Lu

President and CEO

HebeCell, MA

Alicia D. Henn

CSO

BioSpherix, Ltd., NY

Zeynep Guillemin

Zeynep Guillemin

Senior Scientist

Voyager Therapeutics, MA

Parameswaran Hari

Parameswaran Hari

Chief Development Officer

Obsidian Therapeutics, MA

Tetsuya Yamagata

Tetsuya Yamagata

Chief Scientific Officer

Modalis Therapeutics Inc., MA

Jesse Kay

Business Development Manager

PROGEN Biotech Inc., AR

Demet (Dee) Sag

Demet (Dee) Sag

Founder

Genome2Life, MA

Greg Kunst

CEO

Aurion Biotech, WA

Jaspreet Khurana

Jaspreet Khurana

Senior Director, mRNA Programming

Strand Therapeutics, MA

Michael Krohn

Executive Vice President

Leading Akribion Genomics, Germany

Erin Kimbrel

President

Astellas Institute for Regenerative Medicine, MA

Victor Hernandez

Victor Hernandez

Chief Scientific Officer

Axovia Therapeutics Ltd, UK

Sally Gu

Senior Associate

Hogan Lovells US LLP, DC

Huiren Zhao

Principle Scientist

Amgen, CA

Elisa Cuevas

Head of NPD

4basebio Discovery Ltd, UK

Nidhi Kotecha

Program Director

Regulatory Affairs, Gates Institute, CO

Shira Orr

CEO & Co-Founder

Envoya Inc., MA

Qi Zhao

Founder, CSO

Enrich Biosystems Inc., CT

Mindy Sadik

Director, Cell Therapy Sciences

Thermo Fisher Scientific, MA

For regular updates bookmark Global Cell & Gene Therapy Summit website

Conference Secretariat:
USG United Scientific Group
A non-profit organization
8105, Suite 112, Rasor Blvd
PLANO, TX 75024

Phone: +1-469-854-2280/81, +1-844-395-4102

Email: cgt@uniscigroup.org
Email: sanvi@cellgenetherapysummit.com
Website: https://www.unitedscientificgroup.org

Subscribe!